About PT-141
PT-141 (Bremelanotide) is a synthetic peptide studied as a melanocortin receptor agonist in neuroscience and receptor pharmacology research. Supplied as a lyophilized powder for laboratory investigations into melanocortin signaling pathways and CNS-associated signaling mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Recent research on PT-141: Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Read Full Study on PubMedQuantification of "Mercy Sex" in Heterosexual Women.
Recent research on PT-141: Quantification of "Mercy Sex" in Heterosexual Women.
Read Full Study on PubMedAdditional Studies
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
Recent research on PT-141: FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
Read on PubMedFemale Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Recent research on PT-141: Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Read on PubMedStrategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Recent research on PT-141: Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Read on PubMedPractical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
Recent research on PT-141: Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
Read on PubMedPolymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.
Recent research on PT-141: Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.
Read on PubMedA biodegradable suction patch for sustainable transbuccal peptide delivery.
Recent research on PT-141: A biodegradable suction patch for sustainable transbuccal peptide delivery.
Read on PubMedRelated Research
Purchase PT-141 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.